Management outlines its pivot toward commercial execution and a revised full-year revenue outlook.
Every AI chip from Nvidia and Broadcom runs through one company's fabs, yet that company trades at a fraction of the valuation its customers command. ...
Nkarta, Inc. (NASDAQ:NKTX), a clinical-stage biotechnology company developing engineered natural killer (NK) cell therapies to treat autoimmune diseas...
Viridian Therapeutics, Inc. (NASDAQ:VRDN), a biotechnology company focused on discovering, developing, and commercializing potentially best-in-class m...
Citigroup analyst Steven Zaccone maintains Ulta Beauty (NASDAQ:ULTA) with a Neutral and raises the price target from $580 to $685.
Faeth Therapeutics (NASDAQ:FTH), a clinical- stage biotechnology company developing multi-node therapies for cancer patients, including its lead progr...
https://www.bloomberg.com/news/articles/2026-11-06/openai-completes-11-billion-portion-of-funding-at-1-25-trillion-value
With a consistent efficacy and safety profile through 56-weeks of follow-up, the Phase 3 SCOUT-HCM clinical trial further reinforces Camzyos as the fi...
Citigroup analyst Steven Zaccone maintains RH (NYSE:RH) with a Neutral and lowers the price target from $166 to $155.
The S&P 500, Nasdaq, and Dow Jones are rated a Sell, citing a likely prolonged bear market through spring. Click here to read more.
What might the results of the 2026 midterm elections mean for your wallet in the near future?
A 7% mortgage can change more than your house payment. See what homebuyers should consider before making their next move.
Travelers Companies (NYSE:TRV) has outperformed the market over the past 15 years by 1.2% on an annualized basis producing an average annual return of...
Democrats’ midterm sweep turned a four-week slide in AI stocks into the Nasdaq 100’s worst day since March 2020, while a 165,000-job October report ke...
TORONTO, November 06, 2026--The median pension plan in the Northern Trust Canada Universe returned -1.5% for the quarter ending September 30 and 4.4% ...
Scott Melker discusses bitcoin (BTC-USD) erasing its losses from a sell-off, Trump Media (DJT)moves bitcoin, and the SEC crypto broker rules hitting ...
Scott Melker discusses how bitcoin's (BTC-USD) latest rebound above $80,000 per token this week was swiftly erased following the massive tech sell-off...
Moderna's Q3 earnings beat estimates on strong COVID-19 vaccine sales, returning to profitability and boosting its 2026 revenue growth outlook.
Meaningful antitumor activity observed at the 3.0 mCi monotherapy dose with 75% disease control rate and durable disease stabilization; one of two con...
Loading...